These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28398849)

  • 1. Reply to A. Braillon.
    Yuan Y; Li B; Qiu J
    J Clin Oncol; 2017 Jun; 35(18):2098-2099. PubMed ID: 28398849
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrence in Early-Stage Hepatocellular Carcinoma: CpG Methylation and Smoking.
    Braillon A
    J Clin Oncol; 2017 Jun; 35(18):2097-2098. PubMed ID: 28398848
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: ""Local recurrence" is not equal to "Local dissemination" after resection for hepatocellular carcinoma".
    Shindoh J; Hasegawa K; Matsuyama Y; Makuuchi M; Kokudo N
    J Hepatol; 2016 Nov; 65(5):1062-1063. PubMed ID: 27448705
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to: Considerations on "Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation".
    Kim SH
    Eur J Surg Oncol; 2019 Apr; 45(4):717-718. PubMed ID: 30803907
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.
    Brown KT; Do R; Gönen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson K; Garcia AR; Beattie CM; Zhao B; Solomon SB; Schwartz LH; DeMatteo RP; Abou-Alfa GK
    J Clin Oncol; 2017 Jan; 35(2):258-259. PubMed ID: 28056199
    [No Abstract]   [Full Text] [Related]  

  • 6. Port Site Recurrences Following Laparoscopic Liver Resection for Hepatocellular Carcinoma: Reply.
    Martin R
    World J Surg; 2016 Jul; 40(7):1780. PubMed ID: 27055662
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to: Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis.
    Shen SL; Wang W; Fu SJ; Peng BG
    Ann Surg Oncol; 2017 Dec; 24(Suppl 3):653-654. PubMed ID: 29124489
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to: "How to better predict microvascular invasion and recurrence of hepatocellular carcinoma".
    Lee S; Kim SH
    J Hepatol; 2017 Nov; 67(5):1120-1121. PubMed ID: 28739111
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence".
    Yang JD; Leise MD
    J Hepatol; 2017 Dec; 67(6):1357. PubMed ID: 28800877
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to: "Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma".
    Sposito C; Mazzaferro V
    J Hepatol; 2014 Jan; 60(1):230-1. PubMed ID: 24018319
    [No Abstract]   [Full Text] [Related]  

  • 11. "Are We Sure that Blood Transfusion is Associated with Recurrence of Hepatocellular Carcinoma After Hepatectomy?": Reply.
    Harada N; Maehara Y
    World J Surg; 2016 Sep; 40(9):2293. PubMed ID: 27172801
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to "Association of blood transfusion during resection for hepatocellular carcinoma with postoperative recurrence and overall survival: A cautionary comment".
    Yang T; Shen F; Schwartz M
    J Hepatol; 2016 Jul; 65(1):229-230. PubMed ID: 27063565
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to "Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing".
    Reig M; Torres F; Mariño Z; Forns X; Bruix J
    J Hepatol; 2016 Oct; 65(4):864-865. PubMed ID: 27255581
    [No Abstract]   [Full Text] [Related]  

  • 14. The authors' reply.
    Nagai S; Abouljoud MS; Moonka D; Yoshida A
    Transplantation; 2014 Mar; 97(6):e33-4. PubMed ID: 24637871
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to: "pre-retrieval reperfusion decreases cancer recurrence after rat ischemic liver graft transplantation".
    Oldani G; Lacotte S; Orci L; Toso C;
    J Hepatol; 2014 Oct; 61(4):962-3. PubMed ID: 24950481
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to "A strong message is needed to address the issue of HCC recurrence after DAA therapy".
    Carrat F; Nahon P; Duclos-Vallée JC; Pageaux GP; Fontaine H; Pol S;
    J Hepatol; 2016 Dec; 65(6):1269-1270. PubMed ID: 27480588
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to: "Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue".
    Sposito C; Mazzaferro V
    J Hepatol; 2014 Mar; 60(3):682-3. PubMed ID: 24216444
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to 'neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?'.
    Lai Q; Lerut J
    Transpl Int; 2014 Aug; 27(8):e82-3. PubMed ID: 24628991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: pre- and post-operative anti-viral therapy is important for patients with hepatitis B virus-related hepatocellular carcinoma - authors' reply.
    Chong CC; Wong VW; Lai PB; Chan HL
    Aliment Pharmacol Ther; 2015 Apr; 41(8):790. PubMed ID: 25781043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.